Skip to main content
Log in

Diagnosis and Management of Atypical Hemolytic Uremic Syndrome In Children: Single Centre Experience

  • Original Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Atypical hemolytic uremic syndrome (aHUS) although rare is the commonest cause of acute renal failure (ARF) in children and has poor prognosis. We present single centre experience of aHUS. Thirty six children (29 males, 7 females) with mean age, 7.9 years presented with ARF, 2 children also had tonic–clonic type convulsions. Their hematology examination revealed hemolytic anemia with s. creatinine (SCr), 5.54 mg/dl. Acute HUS was observed in 75 %, acute on chronic HUS in 19.4 % and patchy cortical necrosis (PCN) in 5.6 % biopsies. Mean 5.4 plasma exchanges (PE) were carried out. Supportive management of anti-hypertensives and prednisone was also given. Recovery end points were establishment of urine output, improvement of SCr and hematological profile. Hematology and renal function profile improved variably in all children, 5.6 % died, relapse was observed in 80.5 % over mean 70 days; 13.9 % children are doing well over mean follow-up of 268.8 days. Thus poor prognosis was observed in 86.1 % children. Children with acute on chronic HUS and PCN did not recover. Six children who recovered had acute HUS. aHUS in Indian children occurs at an older age of around 8 years and chronic/irreversible changes on histopathology examination are harbingers of poor prognosis. PE is life-saving however further research for developing strategies to improve long-term survival is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

ARF:

Acute renal failure

aHUS:

Atypical hemolytic uremic syndrome

CAPD:

Continuous ambulatory peritoneal dialysis

CBC:

Complete blood counts

CRF:

Chronic renal failure

FFP:

Fresh frozen plasma

Hb:

Hemoglobin

HUS:

Hemolytic uremic syndrome

IF:

Immunofluorescence

LDH:

Lactic dehydrogenase

MAHA:

Microangiopathic hemolytic anemia

PE:

Plasma exchange

SCr:

Serum creatinine

TLC:

Total leucocyte count

VWF:

Von Willebrand factor

References

  1. Noris M, Remuzzi G (2010) Genetics and genetic testing in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. Semin Nephrol 30:395–408

    Article  PubMed  Google Scholar 

  2. Noris M, Remuzzi G (2009) Atypical hemolytic uremic syndrome. N Engl J Med 361:1676–1687

    Article  CAS  PubMed  Google Scholar 

  3. Constantinescu AR, Bitzan M, Weiss LS et al (2004) Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis 43:976–982

    Article  PubMed  Google Scholar 

  4. Stuhlinger W, Kourilsky O, Kanfer A, Sraer DJ (1974) Letter: haemolytic uremic syndrome: evidence for intravascular C3 activation. Lancet 2:788–789

    Article  CAS  PubMed  Google Scholar 

  5. Gonzalo A, Mampaso F, Gallego N et al (1981) Hemolytic uremic syndrome with hypocomplementemia and deposits of IgM and C3 in the involved renal tissue. Clin Nephrol 16:193–199

    CAS  PubMed  Google Scholar 

  6. Roberts AW, Gillet EA, Fleming SJ (1991) Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: outcome with plasma exchange. J Clin Apher 6:150–154

    Article  CAS  PubMed  Google Scholar 

  7. Fitzpatrick MM, Dillon MJ, Barratt TM, Trompeter RS (1992) Atypical hemolytic uremic syndrome. In: Kaplan BS, Trompeter RS, Moake JL (eds) Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Marcel Dekker, New York, pp 163–178

    Google Scholar 

  8. Laszik Z, Silva F (1998) Hemolytic-uremic syndrome, thrombotic thrombocytopenia purpura, and systemic sclerosis (systemic scleroderma). In: Jennett JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall’s pathology of the kidney, 5th edn. Lippincott-Raven, Philadelphia, pp 1003–1057

    Google Scholar 

  9. Gasser C, Gautieer E, Steck A et al (1955) Hämolytisch-urämische syndrome: bilaterale Nierenrindennekrosen bei akuten erworbenen hämolytischen Anämien. Schweiz Med Wochenschr 85(905–909):929

    Google Scholar 

  10. Furlan M, Robles R, Galbususera M et al (1998) Von-Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and haemolytic–uraemic syndrome. N Engl J Med 339:1578–1584

    Article  CAS  PubMed  Google Scholar 

  11. Tsai HM, Lian EC (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585–1594

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Moake JL, Rudy CK, Troll KH et al (1982) Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432–1435

    Article  CAS  PubMed  Google Scholar 

  13. Levy GG, Nichols WC, Lian EC et al (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413:488–494

    Article  CAS  PubMed  Google Scholar 

  14. Lammle B (2002) The role of ADAMTS13 in the evaluation and management of patients with thrombotic thrombocytopenic purpura. In: Broudy VC, Abkowitz JL, Vose JM (eds) Hematology 2002: American society of hematology education program book. American Society of Hematology, Washington, pp 319–325

    Google Scholar 

  15. Hwang WYK, Chai LYA, Ng HJ, Goh YT, Tan PHC (2004) Therapeutic plasmapheresis for the treatment of the thrombotic thrombocytopenic purpura-haemolytic uraemic syndromes. Singap Med J 45:219–223

    CAS  Google Scholar 

  16. Hans von Baeyer (2002) Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies. Ther Apher 6:320–328

    Article  PubMed  Google Scholar 

  17. Gianviti A, Perna A, Caringella A et al (1993) Plasma exchange in children with hemolytic-uremic syndrome at risk of poor outcome. Am J Kid Dis 22:264–266

    Article  CAS  PubMed  Google Scholar 

  18. Bandarenko N, Brecher ME (1998) United States thrombotic thrombocytopenic purpura apheresis study group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. J Clin Apher 13:133–141

    Article  CAS  PubMed  Google Scholar 

  19. George NJ, Gilcher RO, Smith JW et al (1998) Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management. J Clin Apher 13:120–125

    Article  CAS  PubMed  Google Scholar 

  20. Dervenoulas J, Tsirigotis P, Bollas G et al (2000) Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses and prognostic factors. A single-center experience of 48 cases. Ann Hematol 79:66–72

    Article  CAS  PubMed  Google Scholar 

  21. Sarode R, Gottschall JL, Aster RH, McFarland JG (1997) Thrombotic thrombocytopenic purpura: early and late responders. Am J Hematol 54:102–107

    Article  CAS  PubMed  Google Scholar 

  22. Byrnes JJ, Moake JL, Klug P, Periman P (1990) Effectivness of the cryosupernatant plasma fraction in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol 34:169–174

    Article  CAS  PubMed  Google Scholar 

  23. Obrador GT, Zeigler ZR, Shadduck RK et al (1993) Effectiveness of cryosupernatant therapy in refractory thrombotic thrombocytopenic purpura. Am J Hematol 42:217–230

    Article  CAS  PubMed  Google Scholar 

  24. Rock G, Shumak KH, Sutton DMC, Buskard NA (1996) Nair RC and the members of the Canadian Apheresis Group. Cryosupernatant as replacement fluid for PEX in thrombotic thrombocytopenic purpura. Brit J Haematol 94:383–386

    Article  CAS  Google Scholar 

  25. Bell WR, Braine HG, Ness PM, Kickler TS (1991) Improved survival in thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: clinical experience in 108 patients. N Engl J Med 325:398–403

    Article  CAS  PubMed  Google Scholar 

  26. Elkins SL, Wilson PP Jr, Files JC, Morrison FS (1996) Thrombotic thrombocytopenic purpura: evolution across 15 years. J Clin Apher 11:173–175

    Article  CAS  PubMed  Google Scholar 

  27. Ramanan AS, Thirumala S, Chandrasekaran V (1999) Thrombotic thrombocytopenic purpura: a single institution experience. J Clin Apher 14:9–13

    Article  CAS  PubMed  Google Scholar 

  28. Lara PN, Coe TL, Zhou H et al (1999) Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Am J Med 107:573–579

    Article  PubMed  Google Scholar 

  29. Henon PH (1991) Traitement du purpura thrombotique thrombopénique: résultats d‘une étude cliniques multicentric randomisée. Presse Médical 20:1761–1767

    CAS  Google Scholar 

  30. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA (1991) Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393–397

    Article  CAS  PubMed  Google Scholar 

  31. Amorosi EL, Ultmann JE (1966) Thrombotic thrombocytopenic purpura: report of 16 cases and a review of the literature. Medicine 45:139–159

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rashmi D. Patel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, R.D., Vanikar, A.V., Gumber, M.R. et al. Diagnosis and Management of Atypical Hemolytic Uremic Syndrome In Children: Single Centre Experience. Indian J Hematol Blood Transfus 30, 342–346 (2014). https://doi.org/10.1007/s12288-013-0262-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-013-0262-3

Keywords

Navigation